HIF-2α-dependent induction of miR-29a restrains T H 1 activity during T cell dependent colitis.
Agnieszka K CzopikEóin N McNameeVictoria VaughnXiangsheng HuangIn Hyuk BangTrent ClarkYanyu WangWei RuanTom T NguyenJoanne C MastersonEunyoung TakSandra FrankColm B CollinsHoward LiCristian Rodríguez-AguayoGabriel Lopez-BeresteinMark E GerichGlenn T FurutaXiaoyi YuanAnil K SoodEdwin F de ZoetenHolger K EltzschigPublished in: Nature communications (2024)
Metabolic imbalance leading to inflammatory hypoxia and stabilization of hypoxia-inducible transcription factors (HIFs) is a hallmark of inflammatory bowel diseases. We hypothesize that HIF could be stabilized in CD4 + T cells during intestinal inflammation and alter the functional responses of T cells via regulation of microRNAs. Our assays reveal markedly increased T cell-intrinsic hypoxia and stabilization of HIF protein during experimental colitis. microRNA screen in primary CD4 + T cells points us towards miR-29a and our subsequent studies identify a selective role for HIF-2α in CD4-cell-intrinsic induction of miR-29a during hypoxia. Mice with T cell-intrinsic HIF-2α deletion display elevated T-bet (target of miR-29a) levels and exacerbated intestinal inflammation. Mice with miR-29a deficiency in T cells show enhanced intestinal inflammation. T cell-intrinsic overexpression of HIF-2α or delivery of miR-29a mimetic dampen T H 1-driven colitis. In this work, we show a previously unrecognized function for hypoxia-dependent induction of miR-29a in attenuating T H 1-mediated inflammation.
Keyphrases
- cell proliferation
- long non coding rna
- endothelial cells
- long noncoding rna
- oxidative stress
- transcription factor
- type diabetes
- single cell
- gene expression
- metabolic syndrome
- ulcerative colitis
- skeletal muscle
- stem cells
- mesenchymal stem cells
- cell therapy
- high fat diet induced
- smoking cessation
- replacement therapy
- genome wide identification
- dna binding